Atlas Trials

KSV01 Injection as the Therapy for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

Clinical trial NCT07246707 · RECRUITING

Trial details

NCT number
NCT07246707
Sponsor
Zhejiang University
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
B-ALL
Start date
2026-01-02
Primary completion
2027-10-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.